05:49 PM EDT, 06/20/2024 (MT Newswires) -- Jon Congleton, Director, Chief Executive Officer, on June 17, 2024, sold 49,313 shares in Mineralys Therapeutics ( MLYS ) for $592,022. Following the Form 4 filing with the SEC, Congleton has control over a total of 926,958 shares of the company, with 926,958 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1933414/000193341424000032/xslF345X03/wk-form4_1718919832.xml